FUBT
NTLA icon

First United Bank & Trust’s Intellia Therapeutics NTLA Stock Holding History

First United Bank & Trust’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Hold
100
– – ﹤0.01% 411
2026
Q1 		$1.28K Hold
100
– – ﹤0.01% 388
2025
Q4 		$899 Hold
100
– – ﹤0.01% 389
2025
Q3 		$1.73K Hold
100
– – ﹤0.01% 410
2025
Q2 		$938 Hold
100
– – ﹤0.01% 384
2025
Q1 		$711 Hold
100
– – ﹤0.01% 400
2024
Q4 		$1.17K Hold
100
– – ﹤0.01% 372
2024
Q3 		$2.06K Hold
100
– – ﹤0.01% 363
2024
Q2 		$2.24K Hold
100
– – ﹤0.01% 378
2024
Q1 		$2.75K Hold
100
– – ﹤0.01% 391
2023
Q4 		$3.05K Buy
+100
New +$2.87K ﹤0.01% 408

Other funds holding NTLA

CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
GITFIT
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

First United Bank & Trust's NTLA Position: Q2 2026 in Review

First United Bank & Trust held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 100 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

First United Bank & Trust first reported a position in NTLA in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.05K in Q4 2023. 50 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • First United Bank & Trust held 100 shares of Intellia Therapeutics worth $1.69K as of Q2 2026.
  • First United Bank & Trust left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #411 holding.
  • First United Bank & Trust first reported a position in Intellia Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • First United Bank & Trust's Intellia Therapeutics position peaked at $3.05K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.